Immunovant Inc’s recent filing unveils that its Chief Executive Officer Salzmann Peter unloaded Company’s shares for reported $0.36 million on Apr 09 ’25. In the deal valued at $12.99 per share,28,094 shares were sold. As a result of this transaction, Salzmann Peter now holds 1,186,512 shares worth roughly $17.42 million.
Then, Fromkin Andrew J. sold 8,000 shares, generating $156,769 in total proceeds. Upon selling the shares at $19.60, the Director now owns 91,913 shares.
Before that, ANDREW J FROMKIN bought 8,000 shares. Immunovant Inc shares valued at $156,160 were divested by the Director at a price of $19.52 per share.
Jefferies initiated its Immunovant Inc [IMVT] rating to a Hold in a research note published on March 03, 2025; the price target was $20. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who decreased its forecast for the stock in early January from “an Outperform” to “a Peer perform”. Oppenheimer maintained its rating on October 09, 2024. It rated IMVT as “an Outperform”.
Price Performance Review of IMVT
On Friday, Immunovant Inc [NASDAQ:IMVT] saw its stock fall -0.74% to $14.68. Over the last five days, the stock has gained 0.69%. Immunovant Inc shares have fallen nearly -40.73% since the year began. Nevertheless, the stocks have fallen -52.46% over the past one year. While a 52-week high of $34.47 was reached on 01/02/25, a 52-week low of $12.72 was recorded on 04/09/25. SMA at 50 days reached $18.87, while 200 days put it at $25.85.
Levels Of Support And Resistance For IMVT Stock
The 24-hour chart illustrates a support level at 14.34, which if violated will result in even more drops to 14.00. On the upside, there is a resistance level at 14.98. A further resistance level may holdings at 15.29. The Relative Strength Index (RSI) on the 14-day chart is 36.72, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.24, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 70.64%. Stochastics %K at 28.58% indicates the stock is a holding.
How much short interest is there in Immunovant Inc?
A steep rise in short interest was recorded in Immunovant Inc stocks on 2025-03-31, growing by 4.29 million shares to a total of 19.68 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 15.39 million shares. There was a rise of 21.81%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 28, 2024 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $50 price target.
